SCHEMBL21065192

SCHEMBL21065192

Cc1cccc(-c2nnc([C@@H]3CCCN3)o2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.51
SMN1; SMN2 Q16637 5/20 0.51
NPC1 O15118 4/20 0.51
RAB9A P51151 4/20 0.51
TSHR P16473 1/20 0.51
TLR9 Q9NR96 1/20 0.49
TLR8 Q9NR97 1/20 0.49
TLR7 Q9NYK1 1/20 0.49
TP53 P04637 3/20 0.48
MAPT P10636 3/20 0.48
CYP1A2 P05177 3/20 0.47
CYP2C9 P11712 3/20 0.47
CYP2C19 P33261 3/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
ALDH1A1 P00352 3/20 0.47
POLB P06746 1/20 0.47
HSD17B10 Q99714 1/20 0.47
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19385363 0.86 USP30 (0.54) HPGDSMN1; SMN2NPC1RAB9ATSHR
SCHEMBL13114282 0.85 ALDH1A1 (0.57) HPGDSMN1; SMN2NPC1RAB9ATSHR
SCHEMBL16463737 0.84 CYP2C19 (0.55) HPGDSMN1; SMN2NPC1RAB9ATLR9
SCHEMBL16463738 0.84 CYP2C19 (0.55) HPGDSMN1; SMN2NPC1RAB9ATLR9
SCHEMBL23247961 0.80 CYP2C19 (0.53) HPGDSMN1; SMN2NPC1RAB9ATLR9
SCHEMBL23601703 0.79 MAPT (0.65) HPGDSMN1; SMN2NPC1RAB9ATSHR
SCHEMBL23411415 0.79 MAPT (0.58) HPGDSMN1; SMN2NPC1RAB9ATSHR
Trifluoroacetic Acid SCHEMBL29563517 0.77 USP30 (0.46) HPGDSMN1; SMN2NPC1TSHRTLR9
SCHEMBL21065193 0.76 RAB9A (0.53) HPGDSMN1; SMN2NPC1RAB9ATSHR
SCHEMBL8245036 0.76 NR1H4 (0.68)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2906553-B1 OREXIN RECEPTOR ANTAGONISTS WHICH ARE [ORTHO BI (HETERO )ARYL]-[2-(META BI (HETERO)ARYL)-PYRROLIDIN-1-YL]-METHANONE DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2019-06-26 EP disclosed